Kim, E., Tunset, H. M., Cebulla, J., Vettukattil, R., Helgesen, H., Feuerherm, A. J., . . . Moestue, S. A. (2016). Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model. BMC Cancer.
Citación estilo ChicagoKim, Eugene, et al. "Anti-vascular Effects of the Cytosolic Phospholipase A2 Inhibitor AVX235 in a Patient-derived Basal-like Breast Cancer Model." BMC Cancer 2016.
Cita MLAKim, Eugene, et al. "Anti-vascular Effects of the Cytosolic Phospholipase A2 Inhibitor AVX235 in a Patient-derived Basal-like Breast Cancer Model." BMC Cancer 2016.
Precaución: Estas citas no son 100% exactas.